Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
44 hedge funds and large institutions have $41.6M invested in Marrone Bio Innovations, Inc. in 2018 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 5 closing their positions.
400% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 5
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
83% more funds holding
Funds holding: 24 → 44 (+20)
39% less capital invested
Capital invested by funds: $68.1M → $41.6M (-$26.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.87M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.25M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.48M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$894K |
| 5 |
IAM
ICM Asset Management
Spokane,
Washington
|
+$465K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$37.2M |
| 2 |
CPA
Capital Planning Advisors
Roseville,
California
|
-$66K |
| 3 |
LWAC
Laurel Wealth Advisors (California)
Solana Beach,
California
|
-$40K |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$36K |
| 5 |
Barclays
London,
United Kingdom
|
-$30.1K |
MBII Hedge Fund Activity: Q2 2018 in Review
44 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2018, worth a combined $41.6M — down 39% from $68.1M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new MBII positions and 5 closed out — a net gain of 20 holders — while 9 added to existing stakes and 2 trimmed.
The largest buyer was BlackRock, adding an estimated $4.87M. The largest seller was Waddell & Reed Financial, cutting an estimated $37.2M.
- 44 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2018, up from 24 in Q1 2018.
- Funds reported $41.6M of Marrone Bio Innovations, Inc. stock for Q2 2018, down 39% quarter-over-quarter.
- 25 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2018 and 5 closed out, a net change of +20 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q2 2018 was BlackRock, an estimated $4.87M added.
- The largest Marrone Bio Innovations, Inc. seller in Q2 2018 was Waddell & Reed Financial, an estimated $37.2M sold.
Based on aggregated 13F filings for Q2 2018.